CGTX icon

Cognition Therapeutics
CGTX

Overview Fund Activity

51 hedge funds and large institutions have $4.89M invested in Cognition Therapeutics in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.

Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
10
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$422K
2
CM
2
CM Management
Florida
$168K
3
VPIM
3
Vanguard Personalized Indexing Management
California
$23.6K
4
EFS
4
Essex Financial Services
Connecticut
$16.7K
5
NFC
5
Northeast Financial Consultants
Connecticut
$26.7K

Top Sellers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$0
2
VF
2
Virtu Financial
New York
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$18K
5
VC
5
Voss Capital
Texas
$189K
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
51
UBS Group
Switzerland
$0 1 -41,111 -100%
BCM
52
Bridgeway Capital Management
Texas
– – -31,874 Closed
Jane Street
53
Jane Street
New York
– – -10,040 Closed
Fidelity Investments
54
Fidelity Investments
Massachusetts
$0 1 – –
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$0 400 +400 New
1 2
3